Skip to main content
NIH funding notice RFA-MH-24-150

Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)

Closed on October 17, 2023.

Posted
July 12, 2023
Close date
October 17, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $14,993,866 in first-year total cost, median $14,993,866.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-S (04)]1

Most frequent institutions

  1. YALE UNIVERSITY1
Competing awards under RFA-MH-24-150 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024ProCAN: Psychosis Risk Outcomes Compound Assessment Network1U01MH137298-01BEARDEN, CARRIE ECHO, YOUNGSUN TKANE, JOHN MWOODS, SCOTT WYALE UNIVERSITY, CT$14,993,866ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.